Abstract
Accumulating preclinical and clinical evidence indicates that human mesenchymal stromal cells (MSCs) are good candidates for cell therapy. For clinical applications of MSCs extensive in vitro expansion is required to obtain an adequate number of cells. It is evident that the pursuit for cell quantity must not affect quality, but it is also a fact that in vitro culture conditions affect MSC phenotype. One possible variable is the degree of cell confluence during expansion.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Stem Cell Reviews |
Vol/bind | 9 |
Udgave nummer | 1 |
Sider (fra-til) | 44-58 |
Antal sider | 15 |
ISSN | 1550-8943 |
DOI | |
Status | Udgivet - feb. 2013 |